Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.12
Delayed Data
As of Feb 24
 -0.0031 / -2.52%
Today’s Change
0.07
Today|||52-Week Range
0.71
+38.25%
Year-to-Date
No recent news for Mast Therapeutics Inc.

Today’s Trading

Previous close0.12
Today’s open0.12
Day’s range0.12 - 0.12
Volume4,980,947
Average volume (3 months)8,256,001
Market cap$28.6M
Dividend yield--
Data as of 4:02pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-8.70%
Earnings growth (this year)+20.00%
Earnings growth (next 5 years)+57.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.82

Competitors

 Today’s
change
Today’s
% change
ANTHAnthera Pharmaceutic...+0.00+0.58%
PPHMPPeregrine Pharmaceut...-0.30-1.60%
EYEGEyeGate Pharmaceutic...+0.04+1.42%
NVGNNovogen Ltd+0.02+1.18%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 21, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$0.00
Annual profit (last year)-$39.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Brian M. Culley
CFO, Principal Accounting Officer &
SVP
Brandi L. Roberts
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs